Helicobacter Pylori Infection
📧 Sign up to get email alerts when something new happens for Helicobacter Pylori Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-06-03Clinical Trial Update: Efficacy of 10-day Concomitant Regimen Versus High Dose Dual Therapy in Anti-Helicobacter Pylori Rescue Therapy [Phase 4]
Phase 4 clinical trial comparing a 10-day concomitant regimen with high-dose dual therapy for rescue treatment of Helicobacter pylori infect…
-
CLINICAL_TRIALS trial_result · 2013-05-29Clinical Trial Update: The Effective Treatment of Oral Helicobacter Pylori With the Success Rate of Gastric Eradication [Phase 1, Phase 2]
Phase 1/2 trial evaluating an oral treatment for Helicobacter pylori infection has completed, reporting gastric eradication outcomes.
-
CLINICAL_TRIALS trial_result · 2013-05-03Clinical Trial Update: Helicobacter Pylori Infection in Children With Chronic Idiopathic Thrombocytopenic Purpura [Phase 4]
A Phase 4 trial evaluating Helicobacter pylori infection in children with chronic idiopathic thrombocytopenic purpura has completed.
-
CLINICAL_TRIALS research · 2013-03-22Clinical Trial Update: Effect of Dental Scaling on Helicobacter Pylori Eradication and Reinfection
This clinical trial update describes a study on whether dental scaling affects Helicobacter pylori eradication and reinfection.
-
CLINICAL_TRIALS trial_result · 2013-03-06Clinical Trial Update: Quadruple Therapy Versus Dual Therapy as Rescue Regimens for Helicobacter Pylori Infection [Phase 2]
Phase 2 trial comparing quadruple therapy versus dual therapy as rescue regimens for Helicobacter pylori infection has been completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-02-15Clinical Trial Update: Long-term Follow up Helicobacter Pylori Reinfection Rate After Second-Line Treatment: Bismuth-Containing Quadruple Therapy Versus Moxifloxacin-Based Triple Therapy [Phase 4]
This Phase 4 clinical trial reports long-term reinfection rates after second-line therapy for Helicobacter pylori. It compares bismuth-conta…
-
FDA approval · 2013-01-23FDA Approved: BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE — Supplemental Application (H2-Pharma, LLC)
FDA approved a supplemental application for the fixed-dose combination of bismuth subcitrate potassium, metronidazole, and tetracycline hydr…
-
FDA approval · 2013-01-18FDA Approved: IDKIT HP ONE — Supplemental Application (Meridian Bioscience Israel Ltd)
FDA approved a supplemental application for IDKIT HP ONE by Meridian Bioscience Israel Ltd, enabling expanded labeling for the Helicobacter …
-
CLINICAL_TRIALS trial_result · 2013-01-04Clinical Trial Update: Quadruple Versus Sequential Therapy for Helicobacter Pylori Eradication [NA]
A completed clinical trial compared quadruple therapy to sequential therapy for Helicobacter pylori eradication.
-
CLINICAL_TRIALS trial_result · 2012-12-31Clinical Trial Update: 14-day Quadruple Hybrid vs. Concomitant Therapies for Helicobacter Pylori Eradication [Phase 4]
A Phase 4 clinical trial update comparing a 14-day quadruple hybrid therapy with concomitant regimens for Helicobacter pylori eradication. T…
-
FDA label_change · 2012-12-20FDA Approved: DEXILANT — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for Dexilant (lansoprazole) filed by Takeda, extending its labeling with additional indications.
-
CLINICAL_TRIALS trial_result · 2012-11-21Clinical Trial Update: Helicobacter Pylori Treatment in Immune Thrombocytopenic Purpura (ITP) Patients [Phase 2, Phase 3]
Phase 2/3 trial evaluating Helicobacter pylori eradication therapy in patients with immune thrombocytopenic purpura has completed. The updat…
-
CLINICAL_TRIALS trial_result · 2012-11-16Clinical Trial Update: Efficacy of 10-day and 14-day Sequential Therapy Versus Triple Therapy on the Eradication of Helicobacter Pylori [Phase 4]
Phase 4 trial comparing 10-day and 14-day sequential therapy against standard triple therapy for eradication of Helicobacter pylori.
-
CLINICAL_TRIALS research · 2012-11-14Clinical Trial Update: Community-based Helicobacter Pylori Eradication [Phase 4]
A Phase 4 community-based trial studying Helicobacter pylori eradication is listed. The current status is unknown.
-
CLINICAL_TRIALS research · 2012-11-07Clinical Trial Update: Standard Triple Therapy vs Sequential Therapy in Treatment of H Pylori Infection [NA]
Clinical trial comparing standard triple therapy vs sequential therapy for Helicobacter pylori infection. The current status is UNKNOWN.
-
FDA approval · 2012-11-02FDA Approved: OMEPRAZOLE — Supplemental Application (Lannett Company, Inc.)
FDA approved a supplemental application for omeprazole submitted by Lannett Company, Inc. The approval pertains to a change to the marketed …
-
FDA approval · 2012-10-09FDA Approved: NEXIUM — Supplemental Application (AstraZeneca Pharmaceuticals LP)
FDA approved a supplemental application for Nexium (esomeprazole magnesium) submitted by AstraZeneca Pharmaceuticals LP.
-
FDA approval · 2012-10-09FDA Approved: PRILOSEC — Supplemental Application (Covis Pharma US, Inc)
FDA approved a supplemental application for Prilosec (omeprazole magnesium) by Covis Pharma US, Inc, indicating an approved update to the la…
-
FDA approval · 2012-09-28FDA Approved: NEXIUM — Supplemental Application (AstraZeneca Pharmaceuticals LP)
The FDA approved a supplemental application for Nexium (esomeprazole magnesium) from AstraZeneca Pharmaceuticals LP.
-
FDA approval · 2012-09-28FDA Approved: PREVACID SOLUTAB — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for Prevacid Solutab (lansoprazole) submitted by Takeda Pharmaceuticals America, Inc.
-
CLINICAL_TRIALS trial_result · 2012-09-26Clinical Trial Update: S0701, Trial of Three Antibiotic Regimens to Eradicate Helicobacter Pylori (H. Pylori) [Phase 3]
This Phase 3 trial (S0701) evaluating three antibiotic regimens to eradicate Helicobacter pylori has completed.
-
CLINICAL_TRIALS trial_result · 2012-08-31Clinical Trial Update: Efficacy of Seven-day Combined Rabeprazole Plus Levofloxacin Plus Augmentin for Eradication of Helicobacter Pylori [Phase 4]
Phase 4 trial evaluating a seven-day combination therapy of rabeprazole, levofloxacin, and amoxicillin/clavulanate for Helicobacter pylori e…
-
CLINICAL_TRIALS trial_result · 2012-08-17Clinical Trial Update: Aizthromycin or Clarithromycin in H-pylori Eradication Regimen [Phase 4]
A Phase 4 trial comparing azithromycin (Aizthromycin) and clarithromycin for Helicobacter pylori eradication in peptic ulcer disease and dys…
-
CLINICAL_TRIALS research · 2012-08-17Clinical Trial Update: Control of Helicobacter Pylori Infection by Probiotics [NA]
This entry reports a clinical trial investigating whether probiotics can control Helicobacter pylori infection, with no current status avail…
-
FDA approval · 2012-07-25FDA Approved: CLARITHROMYCIN — Original Application (Rising Pharma Holdings, Inc.)
FDA approved a generic clarithromycin product under an original ANDA from Rising Pharma Holdings, Inc.